Infantile Epileptic Spasm Syndrome Caused by TAF1 Missense Variants: Expanding the Epileptic Phenotype and Revealing Underlying Impairments in Neuronal Excitability and Development
Jan 2026· Human Mutation· Vol 2026· 0 citations· 29 references
Medicine
TL;DR
TAF1 missense variants are established as a novel cause of infantile epileptic spasm syndrome—a previously unrecognized phenotype—thereby expanding the epileptic phenotype of TAF1‐related disorders.
Abstract
Background Pathogenic variants in TAF1 have previously been associated with X‐linked intellectual disability and X‐linked dystonia‐parkinsonism. Epilepsy is observed in approximately 24.4% of affected individuals, ranging from focal seizures to generalized seizures including either tonic‐clonic, tonic, myoclonic, atonic or absences. To date, no cases of infantile epileptic spasm syndrome (IESS) have been associated with this neurogenetic condition. In this study, we are aimed at investigating the association between TAF1 and IESS. Methods We performed whole‐exome sequencing in two unrelated Chinese patients with IESS. Functional consequences were assessed using in vitro overexpression assays, transcriptome profiling of Neuro‐2a cells with stable TAF1 knockdown, morphological, and electrophysiological analyses in primary mouse cortical neurons. Results We identified two novel TAF1 missense variants (c.236C > A, p.T79N; c.4771G > A, p.D1591N) in the two patients. Both novel TAF1 missense variants led to reduced TAF1 protein expression, suggesting a loss‐of‐function mechanism. Transcriptome analysis revealed that TAF1 deficiency resulted in significant downregulation of key neuronal genes involved in axon guidance and epileptogenesis, including Kcnn2, Kcna4, Draxin, and Lgi1. In primary mouse cortical neurons, TAF1 knockdown markedly impaired neurite outgrowth and increased neuronal excitability. Conclusion Our findings establish TAF1 missense variants as a novel cause of IESS—a previously unrecognized phenotype—thereby expanding the epileptic phenotype of TAF1‐related disorders. Furthermore, we demonstrate that TAF1 deficiency contributes to disease pathogenesis by impairing neuronal development and increasing neuronal excitability, likely through the downregulation of Kcnn2, Kcna4, Draxin, and Lgi1.
Background: BRAT1-related disorders constitute a continuous neurodevelopmental spectrum ranging from rigidity and multifocal seizure syndrome, lethal neonatal form (RMFSL) to milder phenotypes characterized by cerebellar involvement and variable developmental impairment. Genotype–phenotype correlations remain incomplet...
Camilla Meossi, Lorenzo Cipriano, Flavio Dal Canto et al.· Medical Science· 0 citations
The pathogenic relevance of the identified variants are underscore the pathogenic relevance of the identified variants and pinpoint their importance for regional diagnostic and genetic counseling strategies.
Riaz Ahmad, Kanwal Ayaz, M. Khan et al.· Neurogenetics· 0 citations
BACKGROUND
Pathogenic variants in KCNA2 are associated with developmental and epileptic encephalopathy 32 (DEE32), but genotype-phenotype correlations remain unclear.
METHODS
Whole-exome sequencing was performed in patients with developmental delay and/or epilepsy. Previously reported KCNA2 variants were reviewed to...
Ji-Yuan Zhang, Song Su, Wan-Dong Hu et al.· Seizure· 0 citations
Variants in GABAA receptor subunits are increasingly implicated in developmental and epileptic encephalopathies. Although GABRA2 variants have been associated with early-onset epilepsy, the functional consequences of individual variants, particularly those located outside canonical ligand-binding and transmembrane pore...
J. De Waele, Marcelo Diaz-Bustamante, Najat Aourz et al.· Neurobiology of Disease· 0 citations
Biallelic loss-of-function variants in NRROS (Negative regulator of reactive oxygen species, previously LRRC33) cause a progressive neurodegenerative disorder characterized by early-onset seizures with brain calcifications. To date, 16 affected individuals from 13 unrelated families have been reported for this conditio...
M. Ganapathi, Sean D. Fraser, Joseph Ryu et al.· HGG advances· 0 citations
CHD2-related neurodevelopmental disorders are increasingly recognized as a distinct group of epileptic encephalopathies with heterogeneous clinical manifestations. Here, we report a 12-year-old female patient with pharmacoresistant epilepsy, mild cognitive impairment (IQ = 56), and extraneurological features including...
A. Zuev, E. Fonova, D. S. Kuznetsova et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.